FY 2023 sbir topic 402 phase II. Enhance the performance of the AI for lymph node detection, segmentation and measurements and develop additional AI models for malignancy classification leveraging…
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91023C00051
- Awardee
-
Carina Medical LLC UEI P14BWS94LNM9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,000,000
Award facts
- Opportunity
-
- BAA75N91022R00027 Solicitation number
- Contract value 100% obligated
- $2,000,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Ashburn, VA 20148, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a $2 million firm fixed price contract to Carina Medical LLC, a minority-owned small business located in Ashburn, Virginia, under the FY 2023 Small Business Innovation Research (SBIR) Topic 402 Phase II program. This total small business set-aside contract, awarded on September 18, 2023, with an ultimate completion date of September 17, 2025, focuses on enhancing artificial intelligence performance for lymph node detection, segmentation, and measurements in multi-modality medical imaging. The project builds upon earlier Phase I work and aims to develop additional AI models for malignancy classification that leverage multi-modality imaging data, advancing diagnostic capabilities in oncology.
Carina Medical LLC specializes in advanced AI and machine learning solutions for medical imaging and clinical applications. The SBIR program, administered by the National Cancer Institute, supports innovative small businesses in developing technologies with commercial potential and societal benefit. This contract represents a significant investment in AI-driven medical imaging technology that could enhance cancer detection and classification processes, supporting NCI's broader mission to reduce cancer burden through technological innovation and scientific advancement.
Description
FY 2023 sbir topic 402 phase II. Enhance the performance of the AI for lymph node detection, segmentation and measurements and develop additional AI models for malignancy classification leveraging multi-modality imaging. Software functionality and u
Quick answers
Who was awarded contract 75N91023C00051?
75N91023C00051 was awarded to Carina Medical LLC by National Cancer Institute (National Institutes of Health) on September 18, 2023.
How much is contract 75N91023C00051 worth?
The government has obligated $2,000,000 on 75N91023C00051.
Was contract 75N91023C00051 competed?
The extent of competition for 75N91023C00051 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award